Scarica l'app Stockscreener
77.78
1.21%
0.93
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Genedx Holdings Corp Borsa (WGS) Ultime notizie
New Highs: What makes GeneDx Holdings Corp stock attractive today2026 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN
Is GeneDx, the Stock Cathie Wood Bought for 7 Straight Days, Actually Cheap? - NAI500
Aug Drivers: Does GeneDx Holdings Corp Equity Warrant stock benefit from AI growth2026 Setups & Technical Pattern Alert System - baoquankhu1.vn
GeneDx Holdings Corp. (WGS) latest stock news and headlines - Yahoo Finance Singapore
GeneDx stock falls as Natera launches competing rare disease test - Investing.com India
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Cathie Wood Just Bought This Small Cap Stock Seven Days Straight: Should Investors Take Note? - Benzinga
Discipline and Rules-Based Execution in WGS Response - Stock Traders Daily
GeneDx at Barclays Conference: Expanding Genetic Testing Horizons - Investing.com South Africa
AI Stocks: What is the Moat Score of GeneDx Holdings Corp2026 Rallies & Reliable Entry Point Trade Alerts - baoquankhu1.vn
$80,000 per child: gene tests shift kids from ER to planned care - Stock Titan
Why Is Zevra Therapeutics Stock Trading Higher Today? - Bitget
GeneDx outlines $540M–$555M 2026 revenue target as company accelerates market expansion with new sales force - MSN
Genedx Earnings Call Signals Strong Genomics Growth - The Globe and Mail
GeneDx (NASDAQ:WGS) Trading Down 5.6%Time to Sell? - MarketBeat
Is GeneDx Holdings (WGS) Pricing In Its Sharp 27% Weekly Share Price Move? - Yahoo Finance
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool
GeneDx Holdings Corp. to Launch Genetic Testing Program with Zevra Therapeutics, Inc. to Support Patients with Suspected Niemann-Pick Disease Type C - marketscreener.com
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C - Yahoo Finance
A Look At GeneDx Holdings (WGS) Valuation After Strong Earnings And Genomics AI Developments - Yahoo Finance
Aug Drivers: What are the risks of holding GeneDx Holdings Corp2026 EndofYear Setup & Short-Term Trading Alerts - baoquankhu1.vn
GeneDx CFO Feeley sells $486k in shares - Investing.com Nigeria
Wall Street Analysts Believe GENEDX HOLDINGS (WGS) Could Rally 77.81%: Here's is How to Trade - Finviz
GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership - Business Wire
GeneDx (WGS) CFO Kevin Feeley acquires 1,986 shares from issuer - Stock Titan
Keith Meister Buys Shares Of GeneDx – Insider Weekends (NASDAQ:WGS) - Seeking Alpha
Setup Watch: Is GeneDx Holdings Corp Equity Warrant a stock for growth or value investors2026 Rallies & Real-Time Buy Zone Alerts - baoquankhu1.vn
Aug Mood: What are the risks of holding GeneDx Holdings Corp2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
GeneDx Holdings Inc. Stock Rises Amid Strong Q4 Results and Market Expansions - timothysykes.com
Setup Watch: What is the long term forecast for GeneDx Holdings Corp Equity Warrant stockQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Trading Action: Can GeneDx Holdings Corp Equity Warrant continue delivering strong returns2025 Stock Rankings & Long Hold Capital Preservation Tips - baoquankhu1.vn
Energy Moves: Can GeneDx Holdings Corp deliver alphaJobs Report & Free Long-Term Investment Growth Plans - baoquankhu1.vn
GeneDx Achieves Strong Q4 Growth Amid Positive Outlook for 2026 - StocksToTrade
GeneDx Stock Climbs After Strong Q4 Results and Bullish 2026 Guidance - timothysykes.com
GeneDx Rides Fiscal Gains with Bright 2026 Forecast - StocksToTrade
GeneDx (WGS) Outperforms With Strong Quarter Results, Positive Earnings Outlook Draws Focus - timothysykes.com
GeneDx Stock Soars Following Strong Q4 Results and Updated 2026 Guidance - StocksToTrade
Hedge Fund and Insider Trading News: Ken Griffin, Paul Singer, Steven A. Cohen, Warren Buffett, Scott Bessent, Sabal Capital Management, Point72 Asset Management, GeneDx Holdings Corp (WGS), DXP Enterprises Inc (DXPE), and More - Insider Monkey
Market Review: Is GeneDx Holdings Corp Equity Warrant showing insider buyingSwing Trade & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Keith Meister Purchases 140,026 Shares of GeneDx (NASDAQ:WGS) Stock - MarketBeat
Insider Buying: GeneDx (NASDAQ:WGS) Director Buys 29,495 Shares of Stock - MarketBeat
GeneDx CFO Feeley sells $486k in shares By Investing.com - Investing.com UK
Corvex management buys GeneDx (WGS) shares worth $13.4 million By Investing.com - Investing.com India
Corvex management buys GeneDx (WGS) shares worth $13.4 million - Investing.com
GeneDx (NASDAQ:WGS) CEO Katherine Stueland Sells 25,459 Shares - MarketBeat
GeneDx (NASDAQ:WGS) CFO Sells $486,360.07 in Stock - MarketBeat
Genedx Holdings Insider Sold Shares Worth $486,370, According to a Recent SEC Filing - marketscreener.com
GeneDx (WGS) CEO reports RSU grant and tax-related share sales - Stock Titan
Free cash flow per share of GeneDx Holdings Corp. Class A – BX:WGS - TradingView
ARK Investment Management LLC Purchases New Stake in GeneDx Holdings Corp. $WGS - MarketBeat
Amova Asset Management Americas Inc. Invests $31.44 Million in GeneDx Holdings Corp. $WGS - MarketBeat
New Blackstone Loan And Refinancing Might Change The Case For Investing In GeneDx Holdings (WGS) - simplywall.st
GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference - Business Wire
GeneDx Shares Rise 7.2% After Analyst Updates - National Today
Tax-driven stock sale by GeneDx (WGS) CFO after RSU vest - Stock Titan
GeneDx (NASDAQ:WGS) Shares Up 7.2%Should You Buy? - MarketBeat
Down 25% in 4 Weeks, Here's Why GENEDX HOLDINGS (WGS) Looks Ripe for a Turnaround - Finviz
Down 25% Over the Past Month, Here’s Why GENEDX HOLDINGS (WGS) May Be Poised for a Rebound - Bitget
GeneDx Secures New $100 Million Term Loan Facility - The Globe and Mail
GeneDx (NASDAQ:WGS) Trading Down 6.6%Should You Sell? - MarketBeat
0.34%
0.59%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):